Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Messmore

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Neurotoxicity associated with systemic high-dose cytosine arabinosideS Nand, H L Messmore, R Patel, et al.
Current Pharmaceutical Design|April 14, 2004
Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature reviewH L Messmore, E Coyne, W H Wehrmacher, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparinsH L Messmore, B Griffin, M Koza, et al.
Annals of Clinical and Laboratory Science|July 1, 1978
Macroglobulinemia of Waldenström diagnosis and managementH L Messmore, J Fareed, S Silberman, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Impact of automation on the quantitation of low molecular weight markers of hemostatic defectsJ Fareed, J M Walenga, R L Bick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Influence of different anticoagulant agents on fibrinopeptide a generationM Tobu, O Iqbal, H L Messmore, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1982
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurementsJ Fareed, H L Messmore, J M Walenga, et al.
Thrombosis Research|April 1, 1993
Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgeryM J Koza, H L Messmore, M E Wallock, et al.
Clinical and Experimental Immunology|August 1, 1986
Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemiasH G Drexler, M Menon, M Klein, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Inadequacy of current prevention strategies for heparin-induced thrombocytopeniaD E Wallis, B E Lewis, H L Messmore, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Neurotoxicity associated with systemic high-dose cytosine arabinosideS Nand, H L Messmore, R Patel, et al.
Current Pharmaceutical Design|April 14, 2004
Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature reviewH L Messmore, E Coyne, W H Wehrmacher, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparinsH L Messmore, B Griffin, M Koza, et al.
Annals of Clinical and Laboratory Science|July 1, 1978
Macroglobulinemia of Waldenström diagnosis and managementH L Messmore, J Fareed, S Silberman, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Impact of automation on the quantitation of low molecular weight markers of hemostatic defectsJ Fareed, J M Walenga, R L Bick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Influence of different anticoagulant agents on fibrinopeptide a generationM Tobu, O Iqbal, H L Messmore, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1982
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurementsJ Fareed, H L Messmore, J M Walenga, et al.
Thrombosis Research|April 1, 1993
Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgeryM J Koza, H L Messmore, M E Wallock, et al.
Clinical and Experimental Immunology|August 1, 1986
Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemiasH G Drexler, M Menon, M Klein, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Inadequacy of current prevention strategies for heparin-induced thrombocytopeniaD E Wallis, B E Lewis, H L Messmore, et al.
Pageof 7